Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG627821 Inhibitors

Eddm13, a gene predicted to localize in the extracellular region, encodes the epididymal protein 13, suggesting a role in intercellular communication or structural functions. While the precise molecular functions of Eddm13 remain to be fully elucidated, understanding its potential inhibition provides valuable insights into the intricate regulatory networks that govern its extracellular functions. The predicted extracellular localization implies involvement in cellular interactions, potentially influencing cellular signaling cascades, or contributing to the structural integrity of the extracellular matrix. Exploring mechanisms of inhibition for Eddm13 involves considering a variety of chemical agents that target key cellular processes. These processes, ranging from oxidative stress modulation to interference with intracellular signaling pathways, offer potential avenues for hindering Eddm13 function. For instance, inhibitors targeting cellular redox balance, such as N-Acetyl-L-cysteine, could impact Eddm13 by altering the oxidative stress levels, suggesting a link between redox status and the protein's extracellular role.

Similarly, compounds affecting major signaling pathways, such as the PI3K/AKT pathway, could indirectly influence Eddm13 by disrupting processes crucial for its predicted extracellular functions. The intricate interplay between these chemical inhibitors and cellular processes reveals a nuanced understanding of the potential regulatory mechanisms that govern Eddm13's extracellular activities. Furthermore, inhibitors disrupting fundamental cellular processes, including protein synthesis (Cycloheximide) or glycolysis (2-Deoxyglucose), may provide insights into how Eddm13's function is intricately tied to these cellular activities. Autophagy inhibitors, such as Bafilomycin A1 and Chloroquine, shed light on the potential connection between Eddm13 and cellular homeostasis, implicating the involvement of autophagy in regulating its extracellular dynamics. Inhibitors targeting specific kinases, such as p38 MAPK (SB203580) and MEK (U0126), offer glimpses into the potential impact of signaling cascades on Eddm13's extracellular functions. Altogether, the diverse mechanisms of inhibition elucidate the complex regulatory landscape of Eddm13 and provide a foundation for further investigations into the intricacies of its extracellular roles.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126, a MEK inhibitor, directly affects the MAPK pathway. This pathway can modulate extracellular protein functions, and inhibiting it may indirectly hinder Eddm13, altering its localization or function in the extracellular region.